Vnitr Lek 2005, 51(7-8):900-904

Haemotherapy and its safety

E. Tesařová^*, D. Fabiánová, A. Pejchalová, B. Kubešová

Transfuzní oddělení a krevní banka FN Brno, Pracoviště medicíny dospělého věku, prim. MUDr. Eva Tesařová

Haemotherapy is characterized as applications of blood products and haemoderivates. Traditionally is haemotherapy associated with risks. Their character and importance changed during the history. Only one initially known immunology risk was associated with an incompatible transfusion in AB0 system administered. This immunology risk was detected shortly after discovery of blood groups in 1901. Infectious risks supported haemotherapy from its birth. In the first instance was detected blood transmission of syphilis. In the seventieth of last century was detected blood transmission of viruses, hepatitis B respectively. In the eightieth and in the nineties of last century infectious risks of haemotherapy were fortified of virus HIV and others types of hepatitis discovery. Currently are global risks of transfusion oriented to adverse immunology character and possible bacterial contamination of blood products. Authors relate probable risks of transmission of transfusion transmitted diseases to others process and describe occurrence of adverse reactions in relationship to haemotherapy.

Keywords: haemotherapy; safety; transfusion reaction; transfusion transmitted diseases; blood products; haemoderivates

Received: April 17, 2005; Accepted: April 17, 2005; Published: July 1, 2005  Show citation